How mission plus performance can lead to sustainable success.

The pink, white and red blob of tissue quivers in a vat of clear goop about the size of a kitchen sink. Graduate students ...

Medical device makers including Abbott, Johnson & Johnson and Medtronic want an exemption from Trump tariffs that could hit ...

Medtronic is capturing demand for its cutting-edge solutions, as recent product launches emerge to drive new growth. With the ...

Medtronic will appoint Renault's finance chief Thierry Pieton as its chief financial officer effective March 3, the medical ...

The Inceptiv data give Medtronic more evidence as it tries to increase sales of a product that drove double-digit growth at ...

Today, I'm going to be maintaining my buy rating. Medtronic's product portfolio and launches continued to show encouraging results in Q2. The company's balance sheet remains A-rated. Finally ...

But a pair of treatments that launched in 2019 are already offsetting Humira's losses. Combined sales of Skyrizi, a psoriasis ...

In the most recent trading session, Medtronic (MDT) closed at $91.99, indicating a +0.63% shift from the previous trading day.

could impede demand for MDT’s diabetes care products. Medtronic presents an attractive opportunity for value and income investors, offering a strong combination of a robust underlying business ...